Murray Guta | Parke-davis Pharmaceutical Research Division Of Warner-lambert Co.
スポンサーリンク
概要
関連著者
-
GAROFALO Elizabeth
Parke-Davis, Research & Development
-
Murray Guta
Parke-davis Pharmaceutical Research Division Of Warner-lambert Co.
-
Garofalo Elizabeth
Parke-davis Pharmaceutical Research Division Of Warner-lambert Co.
-
CHADWICK David
Walton Centre for Neurology & Neurosurgery, University of Liverpool
-
Messmer Silke-lo
Parke-davis Research & Development
-
Chadwick David
Walton Centre For Neurology And Neurosurgery
-
Appleton Richard
Department Of Neurology Alder Hey Children's Hospital
-
BRODIE Martin
Epilepsy Unit, University Department of Medicine and Therapeutics, Western Infirmary
-
Anhut Henning
Parke-davis Research & Development
-
Brodie Martin
Epilepsy Unit Department Of Medicine And Therapeutics Western Infirmary
-
OTTE Andreas
Parke-Davis, Research & Development
-
MATON Stephen
Parke-Davis, Research & Development
-
SAUERMANN Wilhelm
DATAMAP GmbH
-
MURRAY Guta
Parke-Davis, Research & Development
-
Murray Guta
Parke-davis Research & Development
-
Maton Stephen
Parke-davis Research & Development
-
Otte Andreas
Parke-davis Research & Development
-
Halsall Gwyneth
Parke-davis Pharmaceutical Research Division Of Warner-lambert Co.
-
FICHTNER Klaus
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co.
-
LAMOREAUX Linda
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co.
-
ALEXANDER Jeannine
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co.
-
Garofalo Elizabeth
Parke-davis Research & Development
-
Brodie Martin
Epilepsy Research Unit And Department Of Pathological Biochemistry
-
Fichtner Klaus
Parke-davis Pharmaceutical Research Division Of Warner-lambert Co.
-
Lamoreaux Linda
Parke-davis Pharmaceutical Research Division Of Warner-lambert Co.
-
Alexander Jeannine
Parke-davis Pharmaceutical Research Division Of Warner-lambert Co.
著作論文
- Gabapenti versus Lamotrigine Monotherapy : A Double-blind Comparison in Newly Diagnosed Epilepsy
- Gabapentin as Add-On Therapy in Children with Refractory Partial Seizures : A 12-Week, Multicentre, Double-Blind, Placebo-Controlled Study